Creative Biolabs Empowers Researchers to Overcome Hurdles in Complement Drug Development
Creative Biolabs has expanded its complement testing capabilities to help researchers overcome challenges in complement drug development through comprehensive complement activity assays, CH50 functional testing, and hemolysis evaluation services. United States, June 22, 2026 —… Read More »Creative Biolabs Empowers Researchers to Overcome Hurdles in Complement Drug Development
